We are live on
!
Find out more
Chevy Chase Trust Portfolio holdings
AUM
$34.7B
1-Year Est. Return
29.45%
This Fund
S&P 500
This Quarter
Est. Return
+22.49%
1 Year Est. Return
+29.45%
3 Year Est. Return
+102.04%
5 Year Est. Return
+142.29%
10 Year Est. Return
+525.93%
AUM
$24.7B
AUM Growth
+$3.17B
(+15%)
Cap. Flow
-$1.16B
Cap. Flow
% of AUM
-4.72%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
661
New
31
Increased
56
Reduced
513
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$73.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$27.2M |
| 3 |
DexCom
DXCM
|
+$26.6M |
| 4 |
T-Mobile US
TMUS
|
+$18.9M |
| 5 |
ASML
ASML
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$87.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$80.5M |
| 3 |
Microsoft
MSFT
|
+$75.5M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$54.8M |
| 5 |
AGN
Allergan plc
AGN
|
+$49.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.84% |
| 4 | Communication Services | 10.4% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PNC Financial Services
PNC
$101B
| $37M | 0.15% |
351,476
-38,119
| -10% | -$4.02M |
|
152
ConocoPhillips
COP
$141B
| $36.6M | 0.15% |
870,497
-69,001
| -7% | -$2.79M |
|
153
Analog Devices
ADI
$190B
| $36.5M | 0.15% |
297,535
-15,564
| -5% | -$1.71M |
|
154
Baxter International
BAX
$14.2B
| $35.6M | 0.14% |
413,270
-24,151
| -6% | -$2.1M |
|
155
Biogen
BIIB
$30.7B
| $35.4M | 0.14% |
132,416
-22,147
| -14% | -$6.66M |
|
156
Edwards Lifesciences
EW
$51.7B
| $35.2M | 0.14% |
509,698
-33,119
| -6% | -$2.35M |
|
|
SCHW
157
Charles Schwab
SCHW
$187B
| $34.7M | 0.14% |
1,026,981
-85,687
| -8% | -$3.07M |
|
158
Guardant Health
GH
$22.6B
| $34.6M | 0.14% |
426,346
+63,313
| +17% | +$5.1M |
|
159
Waste Management
WM
$91B
| $33.3M | 0.14% |
314,469
-20,041
| -6% | -$2.02M |
|
160
Editas Medicine
EDIT
$442M
| $33.2M | 0.13% |
1,123,484
+93,368
| +9% | +$2.44M |
|
161
Intellia Therapeutics
NTLA
$1.67B
| $32.8M | 0.13% |
1,558,163
+173,351
| +13% | +$2.94M |
|
162
DuPont de Nemours
DD
$19.2B
| $31.9M | 0.13% |
477,710
-32,130
| -6% | -$1.88M |
|
163
General Mills
GIS
$19.7B
| $31.2M | 0.13% |
506,870
-27,116
| -5% | -$1.64M |
|
|
EA
164
DELISTED
Electronic Arts
EA
| $31M | 0.13% |
235,083
-15,629
| -6% | -$1.85M |
|
165
Digital Realty Trust
DLR
$71.7B
| $30.8M | 0.12% |
216,693
-7,430
| -3% | -$1.05M |
|
166
Emerson Electric
EMR
$88.3B
| $30.6M | 0.12% |
492,697
-38,710
| -7% | -$2.2M |
|
|
167
DexCom
DXCM
$32B
| $30.1M | 0.12% |
+297,088
| New | +$26.6M |
|
168
FedEx
FDX
$75.4B
| $30.1M | 0.12% |
214,309
-6,683
| -3% | -$841K |
|
169
L3Harris
LHX
$53.4B
| $29.7M | 0.12% |
175,059
-14,135
| -7% | -$2.66M |
|
170
Centene
CNC
$32.5B
| $29.6M | 0.12% |
466,106
-30,162
| -6% | -$1.96M |
|
171
Exelon
EXC
$47B
| $28.6M | 0.12% |
1,106,447
-59,020
| -5% | -$1.57M |
|
172
eBay
EBAY
$49.8B
| $28.5M | 0.12% |
543,664
-119,232
| -18% | -$5.04M |
|
173
Eaton
ETN
$174B
| $28.2M | 0.11% |
322,831
-29,430
| -8% | -$2.42M |
|
174
General Dynamics
GD
$106B
| $28.1M | 0.11% |
187,739
-13,254
| -7% | -$1.87M |
|
|
WBA
175
DELISTED
Walgreens Boots Alliance
WBA
| $27.8M | 0.11% |
654,783
-33,988
| -5% | -$1.44M |
|
Similar funds
VIA
SAM
Chevy Chase Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Chevy Chase Trust held 661 positions worth $24.7B, up 15% from $21.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Chevy Chase Trust withdrew a net $1.16B in Q2 2020, closing 20 positions and reducing 513 holdings. Its most notable exit was Allergan plc, an estimated $49.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Chevy Chase Trust opened a new position in DexCom worth $30.1M.
- Chevy Chase Trust's largest Q2 2020 buy was DexCom: 297,088 shares worth $30.1M.
- Chevy Chase Trust added most to RTX Corp in Q2 2020, an estimated $73.5M increase.
- Chevy Chase Trust's biggest Q2 2020 reduction was Apple, cutting an estimated $87.1M.
- Chevy Chase Trust fully exited Allergan plc in Q2 2020, selling an estimated $49.5M.
- Chevy Chase Trust's ten largest holdings make up 27% of its $24.7B portfolio in Q2 2020.
- Chevy Chase Trust opened 31 new positions and closed 20 in Q2 2020.
- Chevy Chase Trust's portfolio value rose 15% quarter-over-quarter to $24.7B.
Based on Chevy Chase Trust's 13F filing for Q2 2020, filed 14 Aug 2020.